Page last updated: 2024-12-09
adapromine
Description
Research Excerpts
Clinical Trials
Roles
Classes
Pathways
Study Profile
Bioassays
Related Drugs
Related Conditions
Protein Interactions
Research Growth
Market Indicators
Description
adapromine: RN given refers to parent cpd [Medical Subject Headings (MeSH), National Library of Medicine, extracted Dec-2023]
Cross-References
| ID Source | ID |
|---|---|
| PubMed CID | 547499 |
| SCHEMBL ID | 21712133 |
| MeSH ID | M0148412 |
Synonyms (29)
| Synonym |
|---|
| tricyclo(3.3.1.1(3,7))decane-1-methaneamine, alpha-ethyl- |
| EN300-31955 |
| 1-adamantan-1-yl-propylamine |
| 1-(1-adamantyl)propan-1-amine |
| TIMTEC1_005648 |
| OPREA1_839342 |
| EU-0052744 |
| 1-(tricyclo[3.3.1.1~3,7~]dec-1-yl)propan-1-amine |
| STK301795 |
| adapromine |
| NCGC00173643-01 |
| 1-(1-adamantyl)propan-1-amine hydrochloride |
| HMS1550A16 |
| AKOS000307998 |
| AKOS006239073 |
| 1-(adamantan-1-yl)propan-1-amine |
| 60196-90-9 |
| 1-(1-adamantyl)-1-propanamine # |
| propanamine, 1-(1-adamantyl)- |
| RKPSOUZGYPZAHW-UHFFFAOYSA-N |
| mfcd01838799 |
| 1-(1-adamantyl)-1-propanamine |
| Z56347591 |
| [1-(1-adamantyl)propyl]amine |
| Q15634070 |
| DTXSID70975615 |
| SCHEMBL21712133 |
| BS-38342 |
| CS-0295822 |
Research Excerpts
[information is derived through text-mining from research data collected from National Library of Medicine (NLM), extracted Dec-2023]
Bioassays (2)
| Assay ID | Title | Year | Journal | Article |
|---|---|---|---|---|
| AID540299 | A screen for compounds that inhibit the MenB enzyme of Mycobacterium tuberculosis | 2010 | Bioorganic & medicinal chemistry letters, Nov-01, Volume: 20, Issue:21 | Synthesis and SAR studies of 1,4-benzoxazine MenB inhibitors: novel antibacterial agents against Mycobacterium tuberculosis. |
| AID588519 | A screen for compounds that inhibit viral RNA polymerase binding and polymerization activities | 2011 | Antiviral research, Sep, Volume: 91, Issue:3 | High-throughput screening identification of poliovirus RNA-dependent RNA polymerase inhibitors. |
| [information is prepared from bioassay data collected from National Library of Medicine (NLM), extracted Dec-2023] | ||||
Research
Studies (5)
| Timeframe | Studies, This Drug (%) | All Drugs % |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 3 (60.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 2 (40.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| [information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023] | ||
Market Indicators
Research Demand Index: 19.82
According to the monthly volume, diversity, and competition of internet searches for this compound, as well the volume and growth of publications, there is estimated to be moderate demand-to-supply ratio for research on this compound.
| This Compound (19.82) All Compounds (24.57) |
Study Types
| Publication Type | This drug (%) | All Drugs (%) |
|---|---|---|
| Trials | 0 (0.00%) | 5.53% |
| Reviews | 0 (0.00%) | 6.00% |
| Case Studies | 0 (0.00%) | 4.05% |
| Observational | 0 (0.00%) | 0.25% |
| Other | 8 (100.00%) | 84.16% |
| [information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023] | ||